Pulmonx (LUNG) awards 40,000 restricted stock units to director

Rhea-AI Filing Summary

Burns Thomas William reported acquisition or exercise transactions in this Form 4 filing.

Pulmonx Corp director Thomas William Burns received an equity grant in the form of restricted stock units. The award covers 40,000 shares of Pulmonx common stock at a stated price of $0.0000 per share, reflecting a compensation grant rather than a market purchase.

According to the terms, the restricted stock units vest on the earlier of the one-year anniversary of the June 5, 2026 grant date (or the next business day) or the date of the Annual Meeting of the Stockholders for the year after the grant. Following this grant, Burns directly holds 113,399 shares of Pulmonx common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Burns Thomas William

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	40,000	$0.00	--

Holdings After Transaction: Common Stock — 113,399 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSU grant size: 40,000 shares Grant price: $0.0000 per share Holdings after grant: 113,399 shares +1 more

4 metrics

RSU grant size 40,000 shares Restricted Stock Units granted to director on June 5, 2026

Grant price $0.0000 per share Stated price for RSU award, indicating compensation grant

Holdings after grant 113,399 shares Total Pulmonx common stock directly owned after transaction

Vesting trigger date June 5, 2026 One-year anniversary referenced as vesting condition for RSUs

Key Terms

Restricted Stock Units, RSU Grant, Annual Meeting of the Stockholders

3 terms

Restricted Stock Units financial

"Represents grant of Restricted Stock Units ("RSU Grant") payable solely in common stock"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

RSU Grant financial

"Represents grant of Restricted Stock Units ("RSU Grant") payable solely in common stock"

Annual Meeting of the Stockholders financial

"or (ii) the date of the Annual Meeting of the Stockholders for the year subsequent"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Burns Thomas William

(Last) (First) (Middle)

C/O PULMONX CORPORATION

700 CHESAPEAKE DRIVE

(Street)

REDWOOD CITY CALIFORNIA 94063

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Pulmonx Corp [ LUNG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/05/2026		A		40,000(1)	A	$0	113,399	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents grant of Restricted Stock Units ("RSU Grant") payable solely in common stock of the Issuer that vest on the earlier of (i) the one-year anniversary of the date of grant of June 5, 2026, or if such date is not a business day, then on the next business day, or (ii) the date of the Annual Meeting of the Stockholders for the year subsequent to the date such RSU Grant is made.

	/s/ David Aaron Lehman, Attorney-in-Fact	06/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Pulmonx (LUNG) report for Thomas William Burns?

Pulmonx reported that director Thomas William Burns received a grant of 40,000 restricted stock units payable in common stock. The award is compensation-based, carries a stated price of $0.0000 per share, and increases his direct holdings to 113,399 common shares.

How many Pulmonx (LUNG) shares does Thomas William Burns hold after this Form 4?

After the reported grant, Thomas William Burns directly holds 113,399 shares of Pulmonx common stock. This total includes the 40,000-share restricted stock unit award reported in the filing, reflecting his updated ownership position as a company director.

What are the vesting terms of the 40,000 Pulmonx (LUNG) RSUs granted to Thomas William Burns?

The 40,000 restricted stock units vest on the earlier of the one-year anniversary of the June 5, 2026 grant date, or the date of the Annual Meeting of the Stockholders for the year after the grant, with vesting moving the award into fully owned common shares.

Is the Pulmonx (LUNG) Form 4 transaction a market purchase or a compensation grant?

The transaction is a compensation grant, not a market purchase. The filing shows a transaction code A for an award acquisition and a transaction price of $0.0000 per share, indicating restricted stock units granted as part of director compensation.

What security type was involved in the Pulmonx (LUNG) Form 4 for Thomas William Burns?

The filing involves Pulmonx common stock delivered through restricted stock units. These units are payable solely in common stock upon vesting, aligning director compensation directly with the company’s equity rather than cash payments or derivative instruments.